Gaois

Search direction

Search mode

Filter results

Collections

4 results in 2 documents

  1. #2219740

    Torthaí na seacht staidéar atá ann cheana ó AS JRC EURL ECVAM a chur le chéile chun bunachar sonraí tosaigh a chruthú.

    Combining the results of the existing seven studies from DG JRC EURL ECVAM to create an initial database.

    Definitive adoption (EU, Euratom) 2022/182 of the European Union’s general budget for the financial year 2022

  2. #2671550

    Torthaí na seacht staidéar atá ann cheana ó AS JRC EURL ECVAM a chur le chéile chun bunachar sonraí tosaigh a chruthú.

    Combining the results of the existing seven studies from DG JRC EURL ECVAM to create an initial database.

    Definitive adoption (EU, Euratom) 2023/278 of the European Union’s annual budget for the financial year 2023

  3. #2219728

    In 2017, thug Ard-Stiúrthóireacht an Airmhéain Chomhpháirteach Taighde sa Choimisiúin – Saotharlann Tagartha an Aontais Eorpaigh um Roghanna Malartacha ar Thástáil ar Ainmhithe (AS JRC EURL ECVAM) faoi shraith staidéar chun athbhreithniú a dhéanamh ar shamhlacha neamhainmhithe atá ar fáil agus atá ag teacht chun cinn agus atá á n-úsáid don taighde i seacht réimse galair: 1) galair sa chonair riospráide 2) ailse chíche 3) onceolaíocht-imdhíonach 4) imdhíonghineacht táirgí íocshláinte ardteiripe 5) neamhoird néaraimheathlúcháin, 6) galair chardashoithíocha agus 7) uathimdhíonacht.

    In 2017, the Commission’s Joint Research Centre - European Union Reference Laboratory for alternatives to animal testing (DG JRC EURL ECVAM) embarked on a series of studies to review available and emerging non-animal models (NAM) being used for research in seven disease areas: 1) respiratory tract diseases 2) breast cancer 3) immune-oncology 4) immunogenicity of advanced therapeutic medicinal products 5) neurodegenerative disorders, 6) cardiovascular diseases and 7) autoimmunity.

    Definitive adoption (EU, Euratom) 2022/182 of the European Union’s general budget for the financial year 2022

  4. #2671538

    In 2017, thug Ard-Stiúrthóireacht an Airmheáin Chomhpháirteach Taighde sa Choimisiúin – Saotharlann Tagartha an Aontais Eorpaigh um Roghanna Malartacha ar Thástáil ar Ainmhithe (AS JRC EURL ECVAM) faoi shraith staidéar chun athbhreithniú a dhéanamh ar shamhlacha neamhainmhithe atá ar fáil agus atá ag teacht chun cinn agus atá á n-úsáid don taighde i seacht réimse galair: 1) galair sa chonair riospráide 2) ailse chíche 3) oinceolaíocht-imdhíonach 4) imdhíonghineacht táirgí íocshláinte ardteiripe 5) neamhoird néaraimheathlúcháin, 6) galair chardashoithíocha agus 7) uath-imdhíonacht.

    In 2017, the Commission’s Joint Research Centre - European Union Reference Laboratory for alternatives to animal testing (DG JRC EURL ECVAM) embarked on a series of studies to review available and emerging non-animal models (NAM) being used for research in seven disease areas: 1) respiratory tract diseases 2) breast cancer 3) immune-oncology 4) immunogenicity of advanced therapeutic medicinal products 5) neurodegenerative disorders, 6) cardiovascular diseases and 7) autoimmunity.

    Definitive adoption (EU, Euratom) 2023/278 of the European Union’s annual budget for the financial year 2023